The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation

DA Hesselink, R Bouamar, L Elens… - Clinical …, 2014 - Springer
The calcineurin inhibitor tacrolimus is the backbone of immunosuppressive drug therapy
after solid organ transplantation. Tacrolimus is effective in preventing acute rejection but has …

The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation

DA Hesselink, R Bouamar, L Elens… - Clinical …, 2014 - pubmed.ncbi.nlm.nih.gov
The calcineurin inhibitor tacrolimus is the backbone of immunosuppressive drug therapy
after solid organ transplantation. Tacrolimus is effective in preventing acute rejection but has …

The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ Transplantation

DA Hesselink, R Bouamar, L Elens… - Clinical …, 2014 - search.proquest.com
The calcineurin inhibitor tacrolimus is the backbone of immunosuppressive drug therapy
after solid organ transplantation. Tacrolimus is effective in preventing acute rejection but has …

[引用][C] The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ Transplantation

DA HESSELINK, R BOUAMAR… - Clinical …, 2014 - pascal-francis.inist.fr
The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid
Organ Transplantation CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

[引用][C] The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ Transplantation

DA Hesselink, R Bouamar, L Elens… - Clinical …, 2013 - cir.nii.ac.jp
The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid
Organ Transplantation | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …

The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ Transplantation.

D Hesselink, R Bouamar, L Elens… - Clinical …, 2014 - search.ebscohost.com
The calcineurin inhibitor tacrolimus is the backbone of immunosuppressive drug therapy
after solid organ transplantation. Tacrolimus is effective in preventing acute rejection but has …

The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation.

DA Hesselink, R Bouamar, L Elens… - Clinical …, 2014 - europepmc.org
The calcineurin inhibitor tacrolimus is the backbone of immunosuppressive drug therapy
after solid organ transplantation. Tacrolimus is effective in preventing acute rejection but has …

The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation

D Hesselink, R Bouamar, L Elens… - Clinical …, 2014 - repub.eur.nl
The calcineurin inhibitor tacrolimus is the backbone of immunosuppressive drug therapy
after solid organ transplantation. Tacrolimus is effective in preventing acute rejection but has …

[HTML][HTML] The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation

DA Hesselink, R Bouamar, L Elens… - Clinical …, 2014 - dial.uclouvain.be
The calcineurin inhibitor tacrolimus is the backbone of immunosuppressive drug therapy
after solid organ transplantation. Tacrolimus is effective in preventing acute rejection but has …

The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ Transplantation

DA Hesselink, R Bouamar, L Elens, RHN Schaik… - Clinical …, 2014 - infona.pl
The calcineurin inhibitor tacrolimus is the backbone of immunosuppressive drug therapy
after solid organ transplantation. Tacrolimus is effective in preventing acute rejection but has …